Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 11 | 2024 | 325 | 3.000 |
Why?
|
| Leukocytes | 5 | 2025 | 206 | 1.860 |
Why?
|
| P-Selectin | 4 | 2020 | 77 | 1.740 |
Why?
|
| Vimentin | 4 | 2024 | 66 | 1.540 |
Why?
|
| Leukapheresis | 3 | 2025 | 13 | 1.390 |
Why?
|
| Microfluidics | 3 | 2025 | 19 | 1.060 |
Why?
|
| Membrane Glycoproteins | 3 | 2020 | 412 | 1.020 |
Why?
|
| Intravital Microscopy | 2 | 2022 | 17 | 0.970 |
Why?
|
| Neutrophils | 3 | 2021 | 378 | 0.950 |
Why?
|
| Thrombosis | 6 | 2022 | 519 | 0.910 |
Why?
|
| Cannula | 1 | 2024 | 28 | 0.900 |
Why?
|
| Histones | 3 | 2022 | 534 | 0.880 |
Why?
|
| Cell Adhesion | 2 | 2020 | 319 | 0.800 |
Why?
|
| Respiratory Insufficiency | 2 | 2024 | 231 | 0.790 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2025 | 627 | 0.770 |
Why?
|
| Endothelium, Vascular | 2 | 2018 | 515 | 0.760 |
Why?
|
| Endotoxemia | 2 | 2020 | 58 | 0.760 |
Why?
|
| Liver Transplantation | 7 | 2024 | 1039 | 0.700 |
Why?
|
| Pneumonia | 1 | 2024 | 326 | 0.690 |
Why?
|
| von Willebrand Diseases | 2 | 2022 | 50 | 0.690 |
Why?
|
| Echocardiography | 2 | 2024 | 1052 | 0.650 |
Why?
|
| Acetaminophen | 2 | 2021 | 92 | 0.640 |
Why?
|
| Platelet Aggregation | 2 | 2024 | 121 | 0.630 |
Why?
|
| Recombinant Proteins | 3 | 2021 | 1393 | 0.620 |
Why?
|
| Epithelium, Corneal | 3 | 2021 | 173 | 0.550 |
Why?
|
| Corneal Injuries | 2 | 2021 | 28 | 0.530 |
Why?
|
| Receptors, Proteinase-Activated | 1 | 2015 | 2 | 0.510 |
Why?
|
| Antithrombin III | 1 | 2015 | 25 | 0.500 |
Why?
|
| Corneal Keratocytes | 1 | 2015 | 4 | 0.490 |
Why?
|
| End Stage Liver Disease | 4 | 2024 | 182 | 0.470 |
Why?
|
| Peptide Hydrolases | 1 | 2015 | 141 | 0.470 |
Why?
|
| Cell Separation | 5 | 2025 | 229 | 0.470 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2015 | 108 | 0.460 |
Why?
|
| Hepatocytes | 1 | 2015 | 229 | 0.450 |
Why?
|
| von Willebrand Factor | 5 | 2022 | 195 | 0.440 |
Why?
|
| Microcirculation | 3 | 2022 | 93 | 0.420 |
Why?
|
| Animals | 17 | 2025 | 34145 | 0.420 |
Why?
|
| Serum Albumin | 1 | 2013 | 108 | 0.420 |
Why?
|
| Lung Transplantation | 3 | 2022 | 310 | 0.410 |
Why?
|
| Wound Healing | 2 | 2021 | 458 | 0.400 |
Why?
|
| Endothelium | 2 | 2022 | 72 | 0.370 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2015 | 543 | 0.370 |
Why?
|
| Sepsis | 3 | 2022 | 480 | 0.340 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 3 | 2021 | 145 | 0.330 |
Why?
|
| Mice | 12 | 2024 | 17728 | 0.320 |
Why?
|
| Cystic Fibrosis | 2 | 2022 | 257 | 0.320 |
Why?
|
| Disseminated Intravascular Coagulation | 2 | 2020 | 67 | 0.320 |
Why?
|
| Humans | 38 | 2025 | 124404 | 0.310 |
Why?
|
| Acute-On-Chronic Liver Failure | 2 | 2021 | 64 | 0.300 |
Why?
|
| Child | 23 | 2025 | 24526 | 0.300 |
Why?
|
| Biliary Atresia | 2 | 2023 | 190 | 0.300 |
Why?
|
| Inflammation | 5 | 2022 | 1414 | 0.300 |
Why?
|
| Endothelial Cells | 1 | 2010 | 525 | 0.280 |
Why?
|
| Male | 20 | 2025 | 61028 | 0.280 |
Why?
|
| Cardiomyopathies | 2 | 2023 | 479 | 0.260 |
Why?
|
| Lab-On-A-Chip Devices | 2 | 2024 | 12 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 7 | 2021 | 4425 | 0.260 |
Why?
|
| Multiple Organ Failure | 3 | 2022 | 141 | 0.250 |
Why?
|
| Infant | 12 | 2025 | 12479 | 0.240 |
Why?
|
| Child, Preschool | 13 | 2025 | 14085 | 0.240 |
Why?
|
| Venules | 2 | 2022 | 25 | 0.240 |
Why?
|
| Leukocytosis | 1 | 2025 | 45 | 0.240 |
Why?
|
| Liver | 2 | 2022 | 1761 | 0.230 |
Why?
|
| Leukocyte Count | 1 | 2025 | 247 | 0.230 |
Why?
|
| Death | 1 | 2025 | 70 | 0.230 |
Why?
|
| Factor XIII Deficiency | 1 | 2024 | 3 | 0.230 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2024 | 10 | 0.220 |
Why?
|
| Critical Care | 2 | 2021 | 650 | 0.220 |
Why?
|
| Blood Component Removal | 1 | 2023 | 32 | 0.220 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2021 | 85 | 0.220 |
Why?
|
| Ferritins | 2 | 2021 | 96 | 0.210 |
Why?
|
| Female | 17 | 2025 | 66305 | 0.210 |
Why?
|
| Hospital Costs | 1 | 2024 | 178 | 0.200 |
Why?
|
| Craniocerebral Trauma | 1 | 2024 | 139 | 0.200 |
Why?
|
| Hemostatics | 1 | 2022 | 58 | 0.200 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2024 | 185 | 0.190 |
Why?
|
| Tissue and Organ Procurement | 1 | 2025 | 216 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 1228 | 0.190 |
Why?
|
| Liver Cirrhosis | 4 | 2023 | 834 | 0.190 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2021 | 3 | 0.190 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2021 | 9 | 0.190 |
Why?
|
| Chemical and Drug Induced Liver Injury, Chronic | 1 | 2021 | 3 | 0.190 |
Why?
|
| Hyperemia | 1 | 2021 | 25 | 0.190 |
Why?
|
| Retrospective Studies | 11 | 2024 | 16233 | 0.190 |
Why?
|
| CD18 Antigens | 1 | 2021 | 49 | 0.190 |
Why?
|
| Cell Degranulation | 1 | 2021 | 29 | 0.190 |
Why?
|
| Thromboembolism | 1 | 2022 | 88 | 0.180 |
Why?
|
| Vasculitis | 1 | 2021 | 49 | 0.180 |
Why?
|
| Critical Illness | 6 | 2022 | 598 | 0.180 |
Why?
|
| Mast Cells | 1 | 2021 | 74 | 0.180 |
Why?
|
| Interferometry | 1 | 2020 | 26 | 0.180 |
Why?
|
| Respiration, Artificial | 1 | 2023 | 461 | 0.180 |
Why?
|
| ADAMTS13 Protein | 1 | 2021 | 61 | 0.180 |
Why?
|
| Erythrocytes | 1 | 2021 | 207 | 0.180 |
Why?
|
| Virus Replication | 1 | 2024 | 610 | 0.170 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 133 | 0.170 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2025 | 479 | 0.170 |
Why?
|
| Molecular Docking Simulation | 1 | 2020 | 112 | 0.170 |
Why?
|
| Centrifugation | 3 | 2024 | 25 | 0.160 |
Why?
|
| Protein Domains | 1 | 2020 | 234 | 0.160 |
Why?
|
| Perioperative Care | 1 | 2021 | 197 | 0.160 |
Why?
|
| Tracheostomy | 1 | 2021 | 193 | 0.160 |
Why?
|
| Biliary Tract Diseases | 1 | 2018 | 34 | 0.150 |
Why?
|
| Escherichia coli | 1 | 2024 | 988 | 0.150 |
Why?
|
| Rats | 1 | 2025 | 3687 | 0.150 |
Why?
|
| Bacterial Infections | 1 | 2021 | 306 | 0.150 |
Why?
|
| Extracorporeal Circulation | 1 | 2018 | 55 | 0.150 |
Why?
|
| Typhus, Endemic Flea-Borne | 1 | 2018 | 20 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 580 | 0.150 |
Why?
|
| Coronary Care Units | 1 | 2017 | 36 | 0.140 |
Why?
|
| Plasma Exchange | 1 | 2018 | 84 | 0.140 |
Why?
|
| Fibrin | 3 | 2022 | 66 | 0.140 |
Why?
|
| Transportation of Patients | 1 | 2017 | 58 | 0.140 |
Why?
|
| Renal Replacement Therapy | 1 | 2018 | 142 | 0.140 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 261 | 0.140 |
Why?
|
| Protein Binding | 1 | 2020 | 1749 | 0.130 |
Why?
|
| Patient Admission | 1 | 2017 | 185 | 0.130 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 226 | 0.130 |
Why?
|
| Cornea | 1 | 2021 | 653 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2018 | 265 | 0.130 |
Why?
|
| Toll-Like Receptors | 1 | 2015 | 84 | 0.120 |
Why?
|
| Chemokines | 1 | 2015 | 134 | 0.120 |
Why?
|
| Bile Acids and Salts | 2 | 2023 | 245 | 0.120 |
Why?
|
| Liver Diseases | 1 | 2018 | 366 | 0.120 |
Why?
|
| Anemia | 1 | 2018 | 341 | 0.110 |
Why?
|
| Infant, Newborn | 6 | 2024 | 8184 | 0.110 |
Why?
|
| Platelet Function Tests | 1 | 2013 | 39 | 0.110 |
Why?
|
| Cell Movement | 2 | 2021 | 835 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2015 | 795 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 4355 | 0.090 |
Why?
|
| Blood Coagulation Disorders | 1 | 2012 | 101 | 0.090 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2012 | 98 | 0.090 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 178 | 0.090 |
Why?
|
| Postoperative Complications | 2 | 2024 | 3068 | 0.090 |
Why?
|
| Blood Cell Count | 1 | 2010 | 69 | 0.090 |
Why?
|
| Coinfection | 1 | 2012 | 172 | 0.090 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 61 | 0.090 |
Why?
|
| Risk Factors | 5 | 2023 | 10149 | 0.090 |
Why?
|
| Bile Duct Diseases | 1 | 2010 | 17 | 0.090 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2022 | 174 | 0.090 |
Why?
|
| Adolescent | 7 | 2024 | 19358 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1088 | 0.080 |
Why?
|
| Cytokines | 1 | 2015 | 1279 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 969 | 0.080 |
Why?
|
| Staphylococcus aureus | 1 | 2012 | 459 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2021 | 3753 | 0.080 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2010 | 152 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 2012 | 556 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2024 | 2896 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1684 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2022 | 144 | 0.070 |
Why?
|
| Influenza, Human | 1 | 2012 | 657 | 0.070 |
Why?
|
| Length of Stay | 2 | 2024 | 1308 | 0.060 |
Why?
|
| Heart | 1 | 2010 | 718 | 0.060 |
Why?
|
| Myocardium | 1 | 2010 | 997 | 0.060 |
Why?
|
| Factor XIII | 1 | 2024 | 6 | 0.060 |
Why?
|
| Filtration | 1 | 2024 | 23 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 1245 | 0.060 |
Why?
|
| Extracellular Space | 1 | 2022 | 88 | 0.050 |
Why?
|
| Organ Dysfunction Scores | 1 | 2022 | 48 | 0.050 |
Why?
|
| Organ Transplantation | 1 | 2025 | 164 | 0.050 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2022 | 39 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 171 | 0.050 |
Why?
|
| Incidence | 2 | 2021 | 3086 | 0.050 |
Why?
|
| Adult | 3 | 2023 | 29397 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2022 | 152 | 0.050 |
Why?
|
| Fibrinolysis | 1 | 2022 | 38 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2021 | 12287 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2025 | 486 | 0.050 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2021 | 61 | 0.050 |
Why?
|
| Collagen | 1 | 2022 | 313 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2024 | 368 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2021 | 395 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2021 | 93 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2021 | 169 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2020 | 153 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 241 | 0.040 |
Why?
|
| Models, Animal | 1 | 2021 | 466 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2021 | 502 | 0.040 |
Why?
|
| Regeneration | 1 | 2021 | 203 | 0.040 |
Why?
|
| Waiting Lists | 1 | 2021 | 227 | 0.040 |
Why?
|
| Drug Resistance, Multiple | 1 | 2018 | 49 | 0.040 |
Why?
|
| Cold Ischemia | 1 | 2018 | 20 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2018 | 87 | 0.040 |
Why?
|
| Platelet Activation | 1 | 2018 | 70 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2025 | 1264 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2021 | 1482 | 0.040 |
Why?
|
| Operative Time | 1 | 2018 | 166 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 6273 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2018 | 187 | 0.040 |
Why?
|
| Doxycycline | 1 | 2018 | 117 | 0.040 |
Why?
|
| Macrophages | 1 | 2021 | 618 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2017 | 97 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 2017 | 97 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2017 | 69 | 0.030 |
Why?
|
| Antibodies | 1 | 2018 | 371 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2018 | 349 | 0.030 |
Why?
|
| Cause of Death | 1 | 2018 | 468 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 1892 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2018 | 588 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1102 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2017 | 319 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 1017 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 370 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1417 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3427 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 1320 | 0.030 |
Why?
|
| Methylmalonic Acid | 1 | 2012 | 15 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 1174 | 0.030 |
Why?
|
| Vasoplegia | 1 | 2012 | 10 | 0.020 |
Why?
|
| Disease Progression | 1 | 2018 | 2042 | 0.020 |
Why?
|
| Medical Audit | 1 | 2012 | 99 | 0.020 |
Why?
|
| Phenotype | 2 | 2012 | 4255 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 4554 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2018 | 3268 | 0.020 |
Why?
|
| Dicarbethoxydihydrocollidine | 1 | 2010 | 3 | 0.020 |
Why?
|
| Glycogen | 1 | 2010 | 63 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2010 | 58 | 0.020 |
Why?
|
| Young Adult | 1 | 2024 | 8979 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 6089 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2010 | 197 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 4734 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2010 | 306 | 0.020 |
Why?
|
| Fatigue | 1 | 2010 | 219 | 0.020 |
Why?
|
| United States | 1 | 2024 | 10773 | 0.020 |
Why?
|
| Fibrosis | 1 | 2010 | 432 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2010 | 351 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 292 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 5107 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2416 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 1569 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 3382 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 4535 | 0.010 |
Why?
|